Reprosent

Building the human-signal layer for oncology REPROSENT turns daily patient experience into structured insight so cancer teams can keep people safer on therapy and run smarter trials. We capture what’s been missing in oncology: the between-visit story - symptoms, side effects, and tolerability as patients actually live them. What we do • 1–2 minute daily symptom capture with high adherence • Standardized, regulatory-grade signal for trials and routine care • Clinician-ready reports and dashboards that surface early risk, dosing considerations, and trends Why it matters • Safer dosing & earlier intervention: detect emerging toxicity sooner • Smarter trials: reduce timing bias and missing data; strengthen safety/tolerability readouts • Better experience: patients are heard; clinicians get actionable signal Momentum We’ve executed a multi-year agreement with a national oncology research network and are initiating an initial multi-hundred-patient study. REPROSENT is backed by Y Combinator, Harvard, Bond, and Hustle Fund, and is the recipient of the Astellas Pharma Changing Cancer Care Award. Let’s partner Biopharma sponsors, research networks, and cancer centers building patient-signal infrastructure - let’s connect.